Paper10936799
The removal of uremic toxins.
Dhondt A and 3 others. Kidney Int Suppl, 2000. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. The removal of uremic toxins. Papers, record 10936799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10936799
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Failure, Chronic | Major topic |
| Peritoneal Dialysis, Continuous Ambulatory | Major topic |
| Renal Dialysis | Major topic |
| Uremia | Major topic |
| Creatinine | |
| Humans | |
| Urea |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42506731 | Targeting Uremic Toxins in Chronic Kidney Disease: Current Challenges and Emerging Therapeutic Strategies. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42506731 | PubMed |
| 42395665 | Microparticles at the crossroads of the gut-kidney axis: Mechanistic drivers and therapeutic horizons in hemodialysis. | World J Nephrol | 2026 | https://conductscience.org/library/papers/42395665 | PubMed |
| 42277078 | Gender-specific spKt/V thresholds associated with mortality in maintenance hemodialysis patients: a nationwide Korean cohort study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42277078 | PubMed |
| 41441614 | Toxins and the Kidneys: A Two-Way Street. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/41441614 | PubMed |
| 41142834 | Next- Gen Detox: Nanoparticles strategies for liver and kidney toxin removal. | Toxicol Res (Camb) | 2025 | https://conductscience.org/library/papers/41142834 | PubMed |
| 40868406 | Functional Carbon-Based Materials for Blood Purification: Recent Advances Toward Improved Treatment of Renal Failure and Patient Quality of Life. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40868406 | PubMed |
| 40711145 | Associations Between Uraemic Toxins and Gut Microbiota in Adults Initiating Peritoneal Dialysis. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40711145 | PubMed |
| 40630325 | Temporal Changes in Blood Metabolome Among Patients on Hemodialysis. | Kidney Int Rep | 2025 | https://conductscience.org/library/papers/40630325 | PubMed |
| 40508174 | Binding Capacity and Adsorption Stability of Uremic Metabolites to Albumin-Modified Magnetic Nanoparticles. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508174 | PubMed |
| 40469737 | Toward an effective delivery system of a microbial sink of the uremic toxin, p-cresol; an in vitro study with Thauera aminoaromatica S2. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40469737 | PubMed |
| 40004925 | Benefits and Pitfalls of Uraemic Toxin Measurement in Peritoneal Dialysis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004925 | PubMed |
| 39219638 | Better renal replacement therapy to improve sexual function in female patients with end-stage renal disease: A cross-sectional study. | Curr Urol | 2024 | https://conductscience.org/library/papers/39219638 | PubMed |
| 38766271 | Effects of Kt/Vurea on outcomes according to age in patients on maintenance hemodialysis. | Clin Kidney J | 2024 | https://conductscience.org/library/papers/38766271 | PubMed |
| 38612557 | Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612557 | PubMed |
| 36982449 | Pro-Arrhythmic Potential of Accumulated Uremic Toxins Is Mediated via Vulnerability of Action Potential Repolarization. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982449 | PubMed |
| 36430566 | Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430566 | PubMed |
| 36148604 | Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis. | Acta Physiol (Oxf) | 2022 | https://conductscience.org/library/papers/36148604 | PubMed |
| 35207125 | Mixed Matrix Membranes Adsorbers (MMMAs) for the Removal of Uremic Toxins from Dialysate. | Membranes (Basel) | 2022 | https://conductscience.org/library/papers/35207125 | PubMed |
| 35137203 | Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis. | Nephrol Dial Transplant | 2022 | https://conductscience.org/library/papers/35137203 | PubMed |
| 34987785 | Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine. | Clin Kidney J | 2021 | https://conductscience.org/library/papers/34987785 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10936799
GET https://conductscience.org/api/papers/v1/10936799/cited_by?page=2